Home > Financial Ratios > SHREE GANESH REMEDIES

SHREE GANESH REMEDIES
EV/Core EBITDA

    Back to All Ratios
COMMUNITY POLL
for SHREE GANESH REMEDIES
Please provide your vote to see the results

SHREE GANESH REMEDIES Last 5 Year EV/Core EBITDA History

[Consolidated]

Mar2024Mar2020Mar2019
   EV/Core EBITDA(x) 19.544.094.88

What is the latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES ?

The latest EV/Core EBITDA ratio of SHREE GANESH REMEDIES is 19.54 based on Mar2024 Consolidated results.
Year EV/Core EBITDA
Mar202419.54
Mar20204.09
Mar20194.88

How is EV/Core EBITDA of SHREE GANESH REMEDIES Trending?

Years EV/Core EBITDA % Change
Mar2024 19.54
377.75
Mar2020 4.09
-16.19
Mar2019 4.88 -

Other Financial Ratios of SHREE GANESH REMEDIES


Compare EV/Core EBITDA ratio of peers of SHREE GANESH REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES ₹744.1 Cr 11.4% -3.6% -20% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹390,192.0 Cr 0.3% -4% -6.3% Stock Analytics
DIVIS LABORATORIES ₹161,479.0 Cr 2% -9.6% 33.1% Stock Analytics
CIPLA ₹125,113.0 Cr 1.9% 4.5% -0.8% Stock Analytics
TORRENT PHARMACEUTICALS ₹123,539.0 Cr 0.6% 3.6% 9.2% Stock Analytics
DR REDDYS LABORATORIES ₹103,926.0 Cr 2% -1% -7% Stock Analytics


SHREE GANESH REMEDIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
SHREE GANESH REMEDIES

11.4%

-3.6%

-20%

SENSEX

1.3%

-0.8%

3.2%


You may also like the below Video Courses